| Literature DB >> 34618885 |
Cameron Mertz1, Rebecca Glowinski1, Shira H Cohen1, Sara Mertz1, Fang Ye1, Mark W Hall2, Mark E Peeples1, Tiffany King1, Huanyu Wang3, Amy L Leber3, Pablo J Sanchez4,5,6, Octavio Ramilo1,6, Asuncion Mejias1,6.
Abstract
The burden of coronavirus disease 2019 (COVID-19) in children represents a fraction of cases worldwide, yet a subset of those infected are at risk for severe disease. We measured plasma severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in a cohort of 103 children hospitalized with COVID-19 with diverse clinical manifestations. SARS-CoV-2 RNAemia was detected in 27 (26%) of these children, lasted for a median of 6 (interquartile range, 2-9) days, and was associated with higher rates of oxygen administration, admission to the intensive care unit, and longer hospitalization.Entities:
Keywords: COVID-19; RNAemia; SARS-CoV-2; children; disease severity; infants; outcomes; viremia
Mesh：
Substances：
Year: 2022 PMID： 34618885 PMCID： PMC8763956 DOI： 10.1093/infdis/jiab491
Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 7.759